Assessment of a liver-targeted integrating vector restoring cellular architecture and evaluating safety in preclinical models of infantile liver disease.
Key Takeaways
- Our group has shown liver phenotype rescue using adeno-associated vector (AAV)
- Although causality remains unproven and no additional neoplasms have been reported 6
- They have also showed favourable safety profiles in early-phase in vivo clinical trials